MRC Contribution to a CR-UK and EPSRC Cancer Imaging Initiative

MRC 对 CR-UK 和 EPSRC 癌症成像计划的贡献

• 批准号: MC_G0902167
• 负责人: Herbie Newell
• 金额: $ 382.26万
• 依托单位: CANCER RESEARCH UK
• 依托单位国家: 英国
• 项目类别: Intramural
• 财政年份: 2008
• 资助国家: 英国
• 起止时间: 2008 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=MC_G0902167
• 关键词: MRC; Contribution; CR; UK; EPSRC

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

目前GtR中并没有所有资助研究的摘要。这通常是因为在提交提案时不需要摘要，但也可能是因为摘要中包含个人详细信息等敏感信息。

项目成果

The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice.

• DOI: 10.1371/journal.pone.0081763
• 发表时间: 2013
• 期刊: PloS one
• 影响因子: 3.7
• 作者: Haagensen EJ;Thomas HD;Wilson I;Harnor SJ;Payne SL;Rennison T;Smith KM;Maxwell RJ;Newell DR
• 通讯作者: Newell DR

THE FIRST SINGLE-STEP-SINGLE-POST SYNTHESIS OF 4-[

4-[ 的第一个单步单后合成

• 发表时间: 2009
• 期刊: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
• 影响因子: 1.8
• 作者: Yan Ran

Pharmacologic biomarkers in the development of stratified cancer medicine.

• DOI: 10.1158/1078-0432.ccr-14-0511
• 发表时间: 2014-05-15
• 期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
• 作者: Figg WD;Newell DR
• 通讯作者: Newell DR

THE FIRST SYNTHESIS OF ETHYL 3-[

乙基 3-[ 的首次合成

• 发表时间: 2009
• 期刊: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
• 影响因子: 1.8
• 作者: Yan Ran

The first preparation of all regioisomers of ethyl [

首次制备乙基的所有区域异构体[

• 发表时间: 2008
• 期刊: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
• 影响因子: 1.8
• 作者: Yan Ran